These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16196502)

  • 1. Oncogenes as novel targets for cancer therapy (part III): transcription factors.
    Zhang Z; Li M; Rayburn ER; Hill DL; Zhang R; Wang H
    Am J Pharmacogenomics; 2005; 5(5):327-38. PubMed ID: 16196502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenes as novel targets for cancer therapy (part II): Intermediate signaling molecules.
    Zhang Z; Li M; Rayburn ER; Hill DL; Zhang R; Wang H
    Am J Pharmacogenomics; 2005; 5(4):247-57. PubMed ID: 16078861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenes as novel targets for cancer therapy (part IV): regulators of the cell cycle and apoptosis.
    Zhang Z; Li M; Rayburn ER; Hill DL; Zhang R; Wang H
    Am J Pharmacogenomics; 2005; 5(6):397-407. PubMed ID: 16336004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenes as novel targets for cancer therapy (part I): growth factors and protein tyrosine kinases.
    Zhang Z; Li M; Rayburn ER; Hill DL; Zhang R; Wang H
    Am J Pharmacogenomics; 2005; 5(3):173-90. PubMed ID: 15952871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factors as drug targets in cancer.
    Hurst HC
    Eur J Cancer; 1996 Oct; 32A(11):1857-63. PubMed ID: 8943667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stochastic model of oncogene expression and the relevance of this model to cancer therapy.
    Alfano FD
    Theor Biol Med Model; 2006 Jan; 3():5. PubMed ID: 16448558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting transcription factors for cancer gene therapy.
    Libermann TA; Zerbini LF
    Curr Gene Ther; 2006 Feb; 6(1):17-33. PubMed ID: 16475943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug development of MET inhibitors: targeting oncogene addiction and expedience.
    Comoglio PM; Giordano S; Trusolino L
    Nat Rev Drug Discov; 2008 Jun; 7(6):504-16. PubMed ID: 18511928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid hormone regulation of nuclear proto-oncogenes.
    Schuchard M; Landers JP; Sandhu NP; Spelsberg TC
    Endocr Rev; 1993 Dec; 14(6):659-69. PubMed ID: 8119231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SOX family of genes in cancer development: biological relevance and opportunities for therapy.
    Castillo SD; Sanchez-Cespedes M
    Expert Opin Ther Targets; 2012 Sep; 16(9):903-19. PubMed ID: 22834733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenes: cause or consequence in the development of glial tumors.
    Akbasak A; Sunar-Akbasak B
    J Neurol Sci; 1992 Sep; 111(2):119-33. PubMed ID: 1331337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report of a meeting: molecular basis of cancer therapy.
    Gottesman MM
    J Natl Cancer Inst; 1994 Sep; 86(17):1277-85. PubMed ID: 7914937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonistic functional duality of cancer genes.
    Stepanenko AA; Vassetzky YS; Kavsan VM
    Gene; 2013 Oct; 529(2):199-207. PubMed ID: 23933273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oncogenic transcription factors as splicing regulators].
    Théoleyre O; Baklouti F
    Med Sci (Paris); 2004 Nov; 20(11):1014-9. PubMed ID: 15525498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seventh annual Pezcoller Symposium: cancer genes--functional aspects.
    Mihich E; Housman D
    Cancer Res; 1996 Sep; 56(18):4282-7. PubMed ID: 8797609
    [No Abstract]   [Full Text] [Related]  

  • 17. Oncogene-initiated aberrant signaling engenders the metastatic phenotype: synergistic transcription factor interactions are targets for cancer therapy.
    Denhardt DT
    Crit Rev Oncog; 1996; 7(3-4):261-91. PubMed ID: 9258606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-nuclear oncogenes and the regulation of gene expression in transformed cells.
    Bortner DM; Langer SJ; Ostrowski MC
    Crit Rev Oncog; 1993; 4(2):137-60. PubMed ID: 8380545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proto-oncogenes and oncogenes in epidermal neoplasia.
    Simon MM; Sliutz G; Luger TA
    Exp Dermatol; 1995 Apr; 4(2):65-73. PubMed ID: 7640877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense of oligonucleotides and the inhibition of oncogene expression.
    Prins J; de Vries EG; Mulder NH
    Clin Oncol (R Coll Radiol); 1993; 5(4):245-52. PubMed ID: 8398922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.